Miniaturized oligonucleotide arrays: A new tool for discriminating colonization from infection due to Staphylococcus aureus in diabetic foot ulcers

Diabetes Care

Volumn 30, Issue 8, 2007, Pages 2051-2056

  Sotto, Albert ^a   Richard, Jean Louis ^b   Jourdan, Nathalie ^c   Combescure, Christophe ^c   Bouziges, Nicole ^a,c   Lavigne, Jean Philippe ^a,c  

^a INSERM   (France)

^b Department of Nutrition and Diabetes   (France)

^c DEPARTMENT OF NEUROLOGY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

OLIGONUCLEOTIDE;

ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM IDENTIFICATION; DIABETIC FOOT; DNA MICROARRAY; FEMALE; FOOT ULCER; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; DIABETIC FOOT; DIAGNOSIS, DIFFERENTIAL; DNA, BACTERIAL; FEMALE; FOOT ULCER; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; MINIATURIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 34547658009     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc07-0461     Document Type: Article

References (21)

1. Mayfield JA, Reiber GE, Sanders LJ, Janisse D, Pogach LM: Preventive foot care in people with diabetes. Diabetes Care 21:2161-2177, 1998
2. Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J: The global burden of diabetic foot disease. Lancet 336:1719-1724, 2005
3. Lavery LA, Armstrong DG, Wunderlich RP, Mohler MJ, Wendel CS, Lipsky BA: Risk factors for foot infections in individuals with diabetes. Diabetes Care 29:1288-1293, 2006
4. Lipsky BA, Berendt AR, Deery HG, Embil JM, Joseph WS, Karchmer AW, Le-Frock JL, Lew DP, Mader JT, Norden C, Tan JS: Infectious Diseases Society of America: diagnosis and treatment of diabetic foot infections. Clin Infect Dis 39:885-910, 2004
5. International Working Group on the Diabetic Foot: International consensus on the diabetic foot [article online], 2003. Available from http://www.diabeticfoot-consensus.com. Accessed 7 March 2007
6. Xu L, McLennan SV, Lo L, Natfaji A, Bolton T, Liu Y, Twigg SM, Yue DK: Bacterial load predicts healing rate in neuropathic diabetic foot ulcers. Diabetes Care 30:378-380, 2007
7. Game F, Jeffcoate W: MRSA and osteomyelitis of the foot in diabetes. Diabet Med 21:16-19, 2004
8. Dang CN, Prasad YDM, Boulton AJ, Jude EB: Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem. Diabet Med 20:159-161, 2003
9. Tentolouris N, Petrokkos G, Vallianou N, Zachos C, Daikos GL, Tsapogas P, Markou G, Katsilambros N: Prevalence of methicillin-resistant Staphylococcus aureus in infected and uninfected diabetic foot ulcers. Clin Microbiol Infect 12:186-189, 2006
10. Lipsky BA, Berendt AR: Principles and practice of antibiotic therapy of diabetic foot infections. Diabetes Metab Res Rev 16 (Suppl. 1):S42-S46, 2000
11. Hartemann-Heurtier A, Robert J, Jacqueminet S, Ha Van G, Golmard JL, Jarlier V, Grimaldi A: Diabetic foot ulcers and multidrug-resistant organisms: risk factors and impact. Diabet Med 21:710-715, 2004
12. Monecke S, Ehricht R: Rapid genotyping of methicillin-resistant Staphylococcus aureus (MRSA) isolates using miniaturised oligonucleotide arrays. Clin Microbiol Infect 11:825-833, 2005
13. Lavery LA, Armstrong DG, Murdoch DP, Peters EJ, Lipsky BA: Validation of the Infectious Diseases Society of America's diabetic foot infection classification system. Clin Infect Dis 44:562-565, 2007
14. Soussy CJ, Carret G, Cavallo JD, the Antibiotic Susceptibility Testing Committee of the French Society for Microbiology: Antibiotic susceptibility testing [article online], 2006. Available from http://www. sfm.asso.fr. French Society for Microbiology. Accessed 7 March 2007
15. Lipsky BA: International consensus group on diagnosing and treating the infected diabetic foot: a report from the international consensus on diagnosing and treating the infected diabetic foot. Diabetes Metab Res Rev 20 (Suppl. 1):S68-S77, 2004
16. Heller MJ: DNA microarray technology: devices, systems, and applications. Annu Rev Biomed Eng 4:129-153, 2002
17. Lina G, Piemont Y, Godail-Gamot F, Bes M, Peter MO, Gauduchon V, Vandenesch F, Etienne J: Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 29:1128-1132, 1999
18. Jarraud S, Mougel C, Thioulouse J, Lina G, Meugnier H, Forey F, Nesme X, Etienne J, Vandenesch F: Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease. Infect Immun 70:631-641, 2002
19. Vandenesch F, Etienne J: How to prevent transmission of MRSA in the open community? Euro Surveill 9:5, 2004
20. Robinson DA, Kearns AM, Holmes A, Morrison D, Grundmann H, Edwards G, O'Brien FG, Tenover FC, McDougal LK, Monk AB, Enright MC: Re-emergence of early pandemic Staphylococcus aureus as a community-acquired meticillin-resistant clone. Lancet 365:1256-1258, 2005
21. Dufour P, Gillet Y, Bes M, Lina G, Vandenesch F, Floret D, Etienne J, Richet H: Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis 35:819-824, 2002